Michael Scolaro

Michael Scolaro

Oct 06, 2017

Group 6 Copy 219
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

How do chemical exposures trigger autoimmune diseases?

The cause of onset of autoimmune disease is poorly understood, but may be linked to exposure to certain...

Can albumin from egg whites be used to treat Clostridium difficile infections?

Clostridium difficile infection is a toxin-mediated bacterial infection responsible for 500,000 infections...

How does involvement in kink, fetish or BDSM impact a person's health?

Kink-involved people engage in atypical erotic activities such as bondage, rough sex, and fetish activities...

Backer Badge Funded